<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id><journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id><journal-id journal-id-type="publisher-id">nss</journal-id><journal-title-group><journal-title>Nature and Science of Sleep</journal-title></journal-title-group><issn pub-type="epub">1179-1608</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38911317</article-id><article-id pub-id-type="pmc">11192149</article-id><article-id pub-id-type="publisher-id">445219</article-id><article-id pub-id-type="doi">10.2147/NSS.S445219</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Obstructive Sleep Apnea as a Key Contributor to Mental Stress-Induced Myocardial Ischemia in Female Angina Patients with No Obstructive Coronary Artery Disease</article-title><alt-title alt-title-type="running-authors">Liu et al</alt-title><alt-title alt-title-type="running-title">Liu et al</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Fengyao</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Haochen</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Bai</surname><given-names>Bingqing</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Han</given-names></name><xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yuting</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yu</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Quanjun</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1466-066X</contrib-id><name><surname>Wang</surname><given-names>Shuxia</given-names></name><xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Huan</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Geng</surname><given-names>Qingshan</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="an0002" ref-type="corresp"/></contrib><aff id="aff0001"><label>1</label><institution>School of Medicine, South China University of Technology</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0002"><label>2</label><institution>Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0003"><label>3</label><institution>Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0004"><label>4</label><institution>School of Biomedical Sciences and Engineering, South China University of Technology</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0005"><label>5</label><institution>Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology)</institution>, <addr-line>Shenzhen</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0006"><label>6</label><institution>Department of Nuclear Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Huan Ma, <institution>Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University</institution>, <addr-line>No. 106 Zhongshan Er Road</addr-line>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country>, <phone>Fax +8620-83827812</phone>, Email mahuandoctor@163.com</corresp><corresp id="an0002">Qingshan Geng, <institution>Department of Cardiology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology)</institution>, <addr-line>1080 Cuizhu Road, Luohu District</addr-line>, <addr-line>Shenzhen</addr-line>, <addr-line>Guangdong</addr-line>, <fax>Fax +0755-25533018</fax>, Email gengqsh@163.net</corresp><fn id="ft0001"><label>*</label><p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p></fn></author-notes><pub-date pub-type="epub"><day>17</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>16</volume><fpage>823</fpage><lpage>832</lpage><history><date date-type="received"><day>17</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>05</day><month>6</month><year>2024</year></date></history><permissions><copyright-statement>© 2024 Liu et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Liu et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec><title>Purpose</title><p><citation_analysis attribute="neither">Mental stress induced myocardial ischemia (MSIMI) is regarded as the primary cause of the angina with no obstructive coronary artery disease (ANOCA). Obstructive sleep apnea (OSA) is autonomously linked to obstructive coronary heart disease, hypertension, and sudden cardiac death. Similar to the impact of psychological stress on the cardiovascular system, individuals with OSA experience periodic nocturnal hypoxia, resulting in the activation of systemic inflammation, oxidative stress, endothelial dysfunction, and sympathetic hyperactivity. The contribution of OSA to MSIMI in ANOCA patients is unclear. To explore the prevalence of OSA in ANOCA patients and the correlation between OSA and MSIMI, a prospective cohort of female ANOCA patients was recruited.</citation_analysis></p></sec><sec><title>Patients and Methods</title><p><citation_analysis attribute="positive">We recruited female patients aged 18 to 75 years old with ANOCA and evaluated MSIMI using positron emission tomography-computed tomography. Subsequently, Level III portable monitors was performed to compare the relationship between OSA and MSIMI.</citation_analysis></p></sec><sec><title>Results</title><p><citation_analysis attribute="neither">There is higher REI (7.8 vs 2.6, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">=0.019), ODI (4.7 vs 9.2, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">=0.028) and percentage of OSA (67.74% vs 33.33%, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive">=0.004) in MSIMI patients. The patients diagnosed with OSA demonstrated higher myocardial perfusion imaging scores (SSS: 1.5 vs 3, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="negative"> = 0.005, SDS: 1 vs 3, P = 0.007). Adjusted covariates, the risk of developing MSIMI remained 3.6 times higher in OSA patients (β=1.226, OR = 3.408 (1.200–9.681), </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.021).</citation_analysis></p></sec><sec><title>Conclusion</title><p><citation_analysis attribute="neither">Patients with MSIMI exhibit a greater prevalence of OSA. Furthermore, the myocardial blood flow perfusion in patients with OSA is reduced during mental stress.</citation_analysis></p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>obstructive sleep apnea</kwd><kwd>mental stress induced myocardial ischemia</kwd><kwd>angina with no obstructive coronary artery disease</kwd><kwd>myocardial perfusion imaging</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution>the High-level Hospital Construction Project of Guangdong Provincial People’s Hospital</institution></institution-wrap>
</funding-source></award-group><funding-statement>This work was supported by the High-level Hospital Construction Project of Guangdong Provincial People’s Hospital (DFJH201811, DFJH201922, DFJH2020029), Guangdong Province Medical Science and Technology Research Fund Project (No. B202314) and the grants from Natural Science Foundation of Guangdong Province (No.2021A1515011118, 2021A1515011781).</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="4"/><ref-count count="39"/><page-count count="10"/></counts></article-meta></front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Roughly 66% of females experiencing Angina with no obstructive coronary artery disease (ANOCA).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> Notwithstanding the absence of noteworthy coronary obstruction, these patients frequently exhibit persistent symptoms, recurrent hospitalizations, diminished functional status, heightened adverse cardiovascular events, and utilize healthcare resources with repeated medical evaluations and interventions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="negative"> Therefore, a profound investigation into the risk factors and pathogenesis of ANOCA is of paramount importance.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Our previous studies have reported that the prevalence of mental stress induced myocardial ischemia (MSIMI) in patients with ANOCA was much higher than health control (42.9% VS 2.4%). MSIMI is a temporary ischemic response of the myocardium to mental stress, indicating an impaired cardiovascular response to mental stress and preclinical functional impairment of coronary heart disease in individuals with ANOCA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> The occurrence of MSIMI may be attributed to increased vulnerability of the cardiovascular system to stress due to long-term chronic psychological stress. The underlying mechanisms include sympathetic nervous system hyperactivity, endothelial dysfunction, and enhanced inflammatory responses.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="positive"> Prior research has demonstrated that MSIMI possesses the capacity to incite angina, myocardial infarction, arrhythmia, and left ventricular dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8–11</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">There exists evidence that obstructive sleep apnea (OSA) is autonomously linked to obstructive coronary heart disease, hypertension, and sudden cardiac death.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12–16</xref></citation_analysis><citation_analysis attribute="neither"> OSA is typified by recurrent upper airway blockage during sleep, leading to reduced arterial oxygen saturation, and apnea/hypopnea events are frequently terminated by micro arousals.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Due to periodic nocturnal hypoxia,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> patients with OSA experience systemic inflammatory activation,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> oxidative stress,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> endothelial dysfunction,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> and sympathetic nervous system overactivity,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> which subsequently impairs the cardiovascular system. To date, only a small-scale clinical study has reported the prevalence of OSA in patients with ischemia with no obstructive coronary artery disease,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> and no research has explored the correlation between OSA and MSIMI in ANOCA patients. Given the similarities in the mechanisms of cardiovascular damage due to OSA and MSIMI, it is crucial to investigate the prevalence of OSA and its association with MSIMI in ANOCA patients.</citation_analysis></p>
      <p><citation_analysis attribute="neither">The third edition of the International Classification of Sleep Disorders (ICSD-3) defines OSA as an obstructive respiratory disturbance index (RDI) of ≥ 5 events per hour determined by polysomnography (PSG), along with typical symptoms of OSA, such as unrefreshing sleep, daytime somnolence, fatigue or insomnia, awakening with gasping or choking sensations, loud snoring, or witnessed apneas, or an obstructive RDI of ≥ 15 events per hour even in the absence of symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="positive"> Due to the high prevalence of OSA, evaluating all patients suspected of having OSA with PSG, currently considered the gold standard diagnostic test, entails significant costs. Additionally, opportunities for laboratory testing might be limited in certain areas.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> Home Sleep Apnea Testing (HSAT) is an alternative method for diagnosing adult OSA, which may be more cost-effective and efficient in certain populations. Furthermore, compared to PSG, Level III portable monitors (PM), which are user-friendly and economically efficient, offer similar accuracy for the diagnosis of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Consequently, this study recruited a cohort of female patients with ANOCA. Positron Emission Tomography-Computed Tomography (PET-CT) was utilized to assess the occurrence of MSIMI in ANOCA via myocardial perfusion imaging (MPI). Concurrently, sleep data of the subjects were collected using a Level III PM, aiming to explore the prevalence of OSA in ANOCA patients and the correlation between OSA and MSIMI.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Materials and Methods</title>
      <sec id="s0002-s2001">
        <title>Research Registration</title>
        <p><citation_analysis attribute="neither">This study is currently taking place at the Guangdong Provincial People’s Hospital in Guangzhou, Guangdong, China. The study protocol and procedures were approved by the Ethics Committee at Guangdong Provincial People’s Hospital (number: GDREC2019298H(R3)), and its procedures conformed to standards set by the Declaration of Helsinki.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Study Population</title>
        <p><citation_analysis attribute="negative">Our study focused on female Outpatient and inpatient patients aged between 18 and 75 years old who visited the cardiovascular clinic of the Guangdong Provincial People’s Hospital from 2018 to 2020. Inclusion Criteria involve voluntary informed consent, angina in women with coronary artery stenosis less than 50%, ages between 18 and 75 years, and the ability to cooperate with evaluation and examination procedures. Exclusion Criteria encompass chest pain originating from non-cardiovascular or non-pulmonary diseases, pulmonary embolism, aortic dissection, life-threatening severe arrhythmias, concurrent cardiomyopathy or severe valvular disease, New York Heart Association (NYHA) Class IV heart failure, myocardial infarction within the last month, severe psychiatric illness like schizophrenia with a risk of suicide, history of alcohol, medication abuse or drug abuse within the last year, serious primary diseases or dysfunctions in lungs, liver, kidneys, hematopoietic or immune systems, use of antidepressants or anxiety medications in the four weeks prior to the study, participation in any clinical drug trials within the last 12 weeks, and cognitive impairments or inability to comply with study requirements. Qualified participants will receive comprehensive verbal instructions regarding the study’s objectives and nature, allowing them sufficient time to make an informed decision about their participation. Prior to enrollment, written informed consent will be obtained from all participants, and strict confidentiality measures will be implemented for all data collected.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Collection of baseline demographic and clinical characteristics was performed for the participants. This included assessing the Canadian Cardiovascular Society angina grade, as well as identifying the presence of hyperlipidemia, hypertension, or diabetes, alongside a review of medication history.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Mental Stress Test</title>
        <p><citation_analysis attribute="positive">Prior to the commencement of study assessments, patients are required to maintain hemodynamic and clinical stability for a minimum of 48 hours. The consumption of any food or drugs containing caffeine must be ceased for a minimum of 12 hours prior to the stress test. As the protocol previously published, the patient are required to wear virtual reality (VR) goggles and undergo a 12-minute mental stress test after being adequately rested. The mental stress test comprised of three tasks: (1) the Stroop Color and Word Test; (2) an event that elicits negative affect - participants will be requested to deliver a three-minute speech on a situation that has caused them anger, sadness, or fear to three virtual reality physicians, with only one minute of preparation time. The participants will receive notification that their performance, encompassing the lucidity of their explanation, cognitive and behavioral processes, and outcome of the scenario, will undergo assessment. In the event that they are unable to provide a response, the investigators will pose inquiries to elicit additional data and fulfill the three-minute speech; (3) mental arithmetic task, which involves the sequential subtraction of seven from a three-digit numeral, with emphasis on expeditious computation. Criteria for terminating the stress tests are in </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=445219.docx" ext-link-type="uri">Supplementary Methods</ext-link></underline></citation_analysis><citation_analysis attribute="neither">.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>PET-CT Scan and Myocardial Perfusion Imaging</title>
        <p><citation_analysis attribute="neither">In PET-CT imaging, ammonia labeled with </citation_analysis><citation_analysis attribute="positive"><sup>13</sup></citation_analysis><citation_analysis attribute="neither">NH</citation_analysis><citation_analysis attribute="positive"><sub>3</sub></citation_analysis><citation_analysis attribute="neither"> is used to assess myocardial perfusion. Following its entry into the heart with the bloodstream, </citation_analysis><citation_analysis attribute="positive"><sup>13</sup></citation_analysis><citation_analysis attribute="neither">NH</citation_analysis><citation_analysis attribute="positive"><sub>3</sub></citation_analysis><citation_analysis attribute="neither"> is rapidly absorbed by myocardial cells and converted into metabolites within the cells. The half-life of </citation_analysis><citation_analysis attribute="positive"><sup>13</sup></citation_analysis><citation_analysis attribute="neither">NH</citation_analysis><citation_analysis attribute="positive"><sub>3</sub></citation_analysis><citation_analysis attribute="neither"> is 10 minutes, and its decay produces positrons that annihilate with electrons to generate gamma rays, which are captured by the PET scanner to construct an activity map of the heart. By comparing the uptake of </citation_analysis><citation_analysis attribute="positive"><sup>13</sup></citation_analysis><citation_analysis attribute="neither">NH</citation_analysis><citation_analysis attribute="positive"><sub>3</sub></citation_analysis><citation_analysis attribute="positive"> in myocardial regions, it is possible to evaluate the uniformity of blood flow and identify ischemic areas, providing support for the diagnosis of MSIMI.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Each subject underwent two PET-CT scans, one at rest and another during a mental stress test. The schematic representation of the mental stress and PET scan procedure are in </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=445219.docx" ext-link-type="uri">Supplemental Figure 1</ext-link></underline></citation_analysis><citation_analysis attribute="neither">. Seven minutes after the start of the mental stress test, </citation_analysis><citation_analysis attribute="positive"><sup>13</sup></citation_analysis><citation_analysis attribute="neither">NH</citation_analysis><citation_analysis attribute="positive"><sub>3</sub></citation_analysis><citation_analysis attribute="positive"> was administered, and the patient continued with the stress test until completion. Following the injection, PET scanning was conducted for a duration of 10 minutes. The images were evaluated using a 17-segment model and a five-point scoring system. The commercially available and previously validated Cedars-Sinai software was utilized to calculate the summed stress score (SSS), summed rest score (SRS), and summed difference score (SDS). A myocardial perfusion defect was identified when the SDS ≥3, indicating the occurrence of MSIMI in the patient.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither"> For further details on the PET-CT scans, refer to the </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=445219.docx" ext-link-type="uri">Supplementary Methods</ext-link></underline></citation_analysis><citation_analysis attribute="neither">.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2005">
        <title>Screening for OSA</title>
        <p><citation_analysis attribute="positive">Within seven days of study enrollment, patients were having HSAT to assess for OSA, utilizing the Level III PM (Alice PDx or NightOne; Philips China Investment Co., Ltd., Shanghai, China). Level III PM measures cardiopulmonary parameters, which include oxygen saturation at the fingertip, respiratory variables (eg, effect to breathe and nasal airflow), and a cardiac variable (eg, heart rate and electrocardiogram). An effective event interpretation required a recorded time of at least four hours. Apnea events were documented when there was a reduction of respiratory airflow by ≥ 90% for a duration exceeding 10 seconds. Hypopnea events were documented when two criteria were met: (1) a reduction of respiratory airflow by over 30% for more than 10 seconds and (2) a 3% decrease in oxygen saturation compared to the baseline. The respiratory event index (REI) was calculated by dividing the total number of apnea and hypopnea events by the duration of recorded data in hours. The oxygen desaturation index (ODI) defined as the number of times per hour during the sleep period when the blood oxygen saturation drops by more than 3% on average. We used the REI for the ultimate scoring of OSA severity. Depending on the value of the REI, OSA is classified into three categories: mild (5–14 events/hour), moderate (15–29 events/hour), and severe (≥30 events/hour). A cutoff REI ≥5 events/h was used to define the existence of OSA, and those with REI &lt; 5 events/h were considered without OSA.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2006">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="positive">Continuous variables that follow a normal distribution are typically represented by Means ± SD, whereas non-normally distributed variables are described by the Median (Q1/Q3). Categorical variables are typically reported as numbers and percentages. During univariate analysis, differences between groups for continuous variables were assessed using either the One Way ANOVA or Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">U</italic></citation_analysis><citation_analysis attribute="positive">-test, while differences between groups for categorical variables were evaluated using either the Chi-Square test or Fisher’s exact test. The Pearson correlation test is employed to analyze continuous grade data, followed by the correction of covariates through Logistic Regression Analysis subsequent to univariate analysis. Three multivariable models were conducted: Model one only include OSA; in Model two, BMI was adjusted; Model three was adjusted for the variables in model two plus a combination variable called cardiovascular disease (CVD) risk factors (which combined smoking, hypertension, diabetes, and hyperlipidemia). The statistical analysis was conducted utilizing SPSS 26.0 and R Studio.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Result</title>
      <sec id="s0003-s2001">
        <title>Baseline Characteristics of Patients in MSIMI and Non-MISMI Groups</title>
        <p><citation_analysis attribute="positive">Among the cohort of 70 patients presenting with chest pain and no epicardial coronary stenosis, 55.7% (n=39) were diagnosed with myocardial ischemia and mental stress-induced myocardial ischemia (MSIMI), while the remaining 44.3% (n=31) did not exhibit MSIMI. There was no significant difference in mean age and height between the MSIMI and non-MSIMI groups.</citation_analysis></p>
        <p><citation_analysis attribute="positive">The study findings indicate that MSIMI patients exhibit higher body mass and body mass index (BMI) compared to non-MSIMI patients. However, there is no significant difference in chest pain levels (CCS scale) between the two groups, and other cardiovascular risk factors, including hypertension, hyperlipidemia, diabetes, and history of arrhythmia, do not exhibit any statistical differences. Furthermore, the total cholesterol, triglycerides, and low-density lipoprotein, which are known risk factors for coronary heart disease, do not exhibit any significant differences between the two groups.</citation_analysis></p>
        <p><citation_analysis attribute="neither">In a total sample of 70 people, the prevalence of OSA was very high. Notably, a higher percentage of OSA patients were observed among MSIMI patients (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">). Furthermore, a larger percentage of MSIMI patients exhibit mild to moderate OSA (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Baseline Characteristics of Patients in MSIMI and Non-MISMI Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">ALL N=70</th><th rowspan="1" colspan="1">Non-MSIMI N=39</th><th rowspan="1" colspan="1">MSIMI N=31</th><th rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">53.46±8.5</td><td rowspan="1" colspan="1">52.64±8.27</td><td rowspan="1" colspan="1">54.48±8.81</td><td rowspan="1" colspan="1">0.371</td></tr><tr><td rowspan="1" colspan="1">Height (cm)</td><td rowspan="1" colspan="1">159.21±4.92</td><td rowspan="1" colspan="1">158.49±4.93</td><td rowspan="1" colspan="1">160.13±4.84</td><td rowspan="1" colspan="1">0.167</td></tr><tr><td rowspan="1" colspan="1">Body mass (kg)</td><td rowspan="1" colspan="1">59.93±8.69</td><td rowspan="1" colspan="1">57.62±8.27</td><td rowspan="1" colspan="1">62.83±8.45</td><td rowspan="1" colspan="1">0.012</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">23.6±2.89</td><td rowspan="1" colspan="1">22.91±2.85</td><td rowspan="1" colspan="1">24.46±2.76</td><td rowspan="1" colspan="1">0.026</td></tr><tr><td rowspan="1" colspan="1">CCS scale I</td><td rowspan="1" colspan="1">50(71.43)</td><td rowspan="1" colspan="1">30(76.92)</td><td rowspan="1" colspan="1">20(64.52)</td><td rowspan="2" colspan="1">0.254</td></tr><tr><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">20(28.57)</td><td rowspan="1" colspan="1">9(23.08)</td><td rowspan="1" colspan="1">11(35.48)</td></tr><tr><td rowspan="1" colspan="1">Hypertension (%)</td><td rowspan="1" colspan="1">16(22.86)</td><td rowspan="1" colspan="1">7(17.95)</td><td rowspan="1" colspan="1">9(29.03)</td><td rowspan="1" colspan="1">0.273</td></tr><tr><td rowspan="1" colspan="1">Hyperlipidemia (%)</td><td rowspan="1" colspan="1">20(28.57)</td><td rowspan="1" colspan="1">12(30.77)</td><td rowspan="1" colspan="1">8(25.81)</td><td rowspan="1" colspan="1">0.648</td></tr><tr><td rowspan="1" colspan="1">Diabetes (%)</td><td rowspan="1" colspan="1">5(7.14)</td><td rowspan="1" colspan="1">2(5.13)</td><td rowspan="1" colspan="1">3(9.68)</td><td rowspan="1" colspan="1">0.649</td></tr><tr><td rowspan="1" colspan="1">Arrhythmia (%)</td><td rowspan="1" colspan="1">8(11.43)</td><td rowspan="1" colspan="1">4(10.26)</td><td rowspan="1" colspan="1">4(12.9)</td><td rowspan="1" colspan="1">0.73</td></tr><tr><td rowspan="1" colspan="1">Total cholesterol (mmol/L)</td><td rowspan="1" colspan="1">5.02±1.09</td><td rowspan="1" colspan="1">5.20±1.00</td><td rowspan="1" colspan="1">4.79±1.18</td><td rowspan="1" colspan="1">0.117</td></tr><tr><td rowspan="1" colspan="1">Triglycerides (mmol/L)</td><td rowspan="1" colspan="1">1.49±0.86</td><td rowspan="1" colspan="1">1.4±0.79</td><td rowspan="1" colspan="1">1.6±0.95</td><td rowspan="1" colspan="1">0.353</td></tr><tr><td rowspan="1" colspan="1">LDL-C (mmol/L)</td><td rowspan="1" colspan="1">3.15±0.81</td><td rowspan="1" colspan="1">3.28±0.73</td><td rowspan="1" colspan="1">2.99±0.89</td><td rowspan="1" colspan="1">0.145</td></tr><tr><td rowspan="1" colspan="1">OSA (%)</td><td rowspan="1" colspan="1">34(48.57)</td><td rowspan="1" colspan="1">13(33.33)</td><td rowspan="1" colspan="1">21(67.74)</td><td rowspan="1" colspan="1">0.004</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: MSIMI, mental stress induce myocardial ischemia; BMI, body mass index; CCS scale, Canada cardiovascular society grading scale for angina; LDL-C, low-density lipoprotein cholesterol; OSA, obstructive sleep apnea.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">The proportion of individuals with OSA in both cohorts. In the MSIMI group, there is a higher proportion of patients with OSA (P = 0.004), with a greater percentage being classified as mild to moderate (P = 0.016).</citation_analysis></p></caption><graphic xlink:href="NSS-16-823-g0001" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: MSIMI, mental stress induce myocardial ischemia; OSA, obstructive sleep apnea.</attrib></fig></citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>The Distinction in Sleep Monitoring Between the MSIMI and Non-MSIMI Cohorts</title>
        <p><citation_analysis attribute="neither">Upon comparing the occurrence of sleep-disordered breathing events between the MSIMI and Non-MSIMI groups, it was discovered that patients with MSIMI exhibited a greater respiratory event (Apnea and Hypopnea, AH times) and a higher REI. Additionally, there was a tendency towards a higher frequency of apnea events and AI, with a greater number of hypopnea events and HI. Furthermore, there were more occurrences of oxygen desaturation events and a higher ODI (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002"><label>Table 2</label><caption><p><citation_analysis attribute="neither">The Distinction in Sleep Monitoring Between the MSIMI and Non-MSIMI Cohorts</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">All N=70</th><th rowspan="1" colspan="1">MSIMI- N=39</th><th rowspan="1" colspan="1">MSIMI+ N=31</th><th rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Apnea</td><td rowspan="1" colspan="1">7.5(2/27.25)</td><td rowspan="1" colspan="1">6(2/21)</td><td rowspan="1" colspan="1">13(2/32)</td><td rowspan="1" colspan="1">0.452</td></tr><tr><td rowspan="1" colspan="1">Duration (min)</td><td rowspan="1" colspan="1">2.1(0.475/9.35)</td><td rowspan="1" colspan="1">1.3(0.5/9.3)</td><td rowspan="1" colspan="1">3.8(0.4/9.5)</td><td rowspan="1" colspan="1">0.492</td></tr><tr><td rowspan="1" colspan="1">AI (h<sup>−1</sup>)</td><td rowspan="1" colspan="1">1.1(0.2/3.175)</td><td rowspan="1" colspan="1">0.7(0.2/2.9)</td><td rowspan="1" colspan="1">1.4(0.2/3.5)</td><td rowspan="1" colspan="1">0.47</td></tr><tr><td rowspan="1" colspan="1">Hypopnea</td><td rowspan="1" colspan="1">24.5(7.75/55.5)</td><td rowspan="1" colspan="1">12(5/41)</td><td rowspan="1" colspan="1">39(20/70)</td><td rowspan="1" colspan="1">0.006</td></tr><tr><td rowspan="1" colspan="1">Duration (min)</td><td rowspan="1" colspan="1">11.85(3.225/23.6)</td><td rowspan="1" colspan="1">5.8(1.8/21)</td><td rowspan="1" colspan="1">14.5(8/25.8)</td><td rowspan="1" colspan="1">0.063</td></tr><tr><td rowspan="1" colspan="1">HI (h<sup>−1</sup>)</td><td rowspan="1" colspan="1">3.3(0.9/6.45)</td><td rowspan="1" colspan="1">1.5(0.6/4.9)</td><td rowspan="1" colspan="1">4.5(2/9.1)</td><td rowspan="1" colspan="1">0.005</td></tr><tr><td rowspan="1" colspan="1">AH</td><td rowspan="1" colspan="1">35.5(11/82)</td><td rowspan="1" colspan="1">20(9/76)</td><td rowspan="1" colspan="1">61(27/99)</td><td rowspan="1" colspan="1">0.024</td></tr><tr><td rowspan="1" colspan="1">Duration (min)</td><td rowspan="1" colspan="1">14.1(4.325/34.025)</td><td rowspan="1" colspan="1">8.8(2.8/33.9)</td><td rowspan="1" colspan="1">22.9(11.3/34.4)</td><td rowspan="1" colspan="1">0.093</td></tr><tr><td rowspan="1" colspan="1">REI (h<sup>−1</sup>)</td><td rowspan="1" colspan="1">4.7(1.525/9.825)</td><td rowspan="1" colspan="1">2.6(1.1/9)</td><td rowspan="1" colspan="1">7.8(3.1/13)</td><td rowspan="1" colspan="1">0.019</td></tr><tr><td rowspan="1" colspan="1">OD</td><td rowspan="1" colspan="1">50(19.75/99.75)</td><td rowspan="1" colspan="1">36(12/86)</td><td rowspan="1" colspan="1">72(25/120)</td><td rowspan="1" colspan="1">0.024</td></tr><tr><td rowspan="1" colspan="1">ODI (h<sup>−1</sup>)</td><td rowspan="1" colspan="1">6.25(2.48/12.65)</td><td rowspan="1" colspan="1">4.7(1.7/9.8)</td><td rowspan="1" colspan="1">9.7(3.7/15.9)</td><td rowspan="1" colspan="1">0.028</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: MSIMI, mental stress induced myocardial ischemia; AI, apnea index; HI, hypopnea index; AH, apnea and hypopnea; REI, respiratory event index; OD, oxygen desaturation; ODI, oxygen desaturation index.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Correlation Between OSA and MSIMI</title>
        <p><citation_analysis attribute="positive">Following univariate analysis, variables exhibiting differences were progressively incorporated into the Logistic regression model. Within the population under investigation, patients with OSA exhibited a 4.2-fold increase in the risk of MSIMI. Notably, even after adjusting for BMI (Model 2), OSA remained a significant factor, while BMI did not exhibit significance within the model. Upon correction for common cardiovascular risk factors (Model 3), the risk persisted (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Logistic Regression Analysis of MSIMI Predictive Factors</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="3" rowspan="1">Model 1</th><th colspan="3" rowspan="1">Model 2</th><th colspan="3" rowspan="1">Model 3</th></tr><tr><th rowspan="1" colspan="1">β</th><th rowspan="1" colspan="1">P</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">β</th><th rowspan="1" colspan="1">P</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">β</th><th rowspan="1" colspan="1">P</th><th rowspan="1" colspan="1">OR (95% CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1">1.435</td><td rowspan="1" colspan="1">0.005</td><td rowspan="1" colspan="1">4.2(1.537–11.476)</td><td rowspan="1" colspan="1">1.236</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">3.443(1.215–9.756)</td><td rowspan="1" colspan="1">1.226</td><td rowspan="1" colspan="1">0.021</td><td rowspan="1" colspan="1">3.408(1.200–9.681)</td></tr><tr><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">0.146</td><td rowspan="1" colspan="1">0.132</td><td rowspan="1" colspan="1">1.157(0.957–1.399)</td><td rowspan="1" colspan="1">0.143</td><td rowspan="1" colspan="1">0.145</td><td rowspan="1" colspan="1">1.153(0.952–1.397)</td></tr><tr><td rowspan="1" colspan="1">CVD risk factor</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">—</td><td rowspan="1" colspan="1">0.293</td><td rowspan="1" colspan="1">0.576</td><td rowspan="1" colspan="1">1.341(0.480–3.745)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="negative">: CVD risk factor including smoking, chronic diseases like hypertension, hyperlipidemia, and diabetes.</citation_analysis></p></fn><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: MSIMI: mental stress induced myocardial ischemia; OSA: obstructive sleep apnea; BMI: body mass index; CVD: Cardiovascular Disease.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
      </sec>
      <sec id="s0003-s2004">
        <title>Characteristics of Patients with OSA</title>
        <p><citation_analysis attribute="positive">The study findings indicate that patients diagnosed with OSAS exhibited advanced age and higher BMI compared to those patients without. However, no significant differences were observed in other cardiovascular risk factors, including chest pain, hypertension, hyperlipidemia, and diabetes. In terms of blood test results, patients with OSA had elevated hemoglobin levels. Additionally, mild increases in liver enzymes and bilirubin were noted, and plasma protein S levels were decreased (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0004"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Characteristics of Patients in OSA and Non-OSA Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">ALL N=70</th><th rowspan="1" colspan="1">Non-OSA N=36</th><th rowspan="1" colspan="1">OSA N=34</th><th rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">53.46±8.5</td><td rowspan="1" colspan="1">49.39±7.83</td><td rowspan="1" colspan="1">57.76±6.99</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Height (cm)</td><td rowspan="1" colspan="1">159.21±4.92</td><td rowspan="1" colspan="1">158.92±5.13</td><td rowspan="1" colspan="1">159.53±4.74</td><td rowspan="1" colspan="1">0.606</td></tr><tr><td rowspan="1" colspan="1">Body mass (kg)</td><td rowspan="1" colspan="1">59.93±8.69</td><td rowspan="1" colspan="1">57.53±7.37</td><td rowspan="1" colspan="1">62.46±9.35</td><td rowspan="1" colspan="1">0.017</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">23.6±2.89</td><td rowspan="1" colspan="1">22.77±2.56</td><td rowspan="1" colspan="1">24.47±3</td><td rowspan="1" colspan="1">0.013</td></tr><tr><td rowspan="1" colspan="1">CCS scale I</td><td rowspan="1" colspan="1">50(71.43)</td><td rowspan="1" colspan="1">27(75)</td><td rowspan="1" colspan="1">23(67.65)</td><td rowspan="2" colspan="1">0.496</td></tr><tr><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">20(28.57)</td><td rowspan="1" colspan="1">9(25)</td><td rowspan="1" colspan="1">11(32.35)</td></tr><tr><td rowspan="1" colspan="1">Hypertension (%)</td><td rowspan="1" colspan="1">16(22.86)</td><td rowspan="1" colspan="1">7(19.44)</td><td rowspan="1" colspan="1">9(26.47)</td><td rowspan="1" colspan="1">0.484</td></tr><tr><td rowspan="1" colspan="1">Hyperlipidemia (%)</td><td rowspan="1" colspan="1">20(28.57)</td><td rowspan="1" colspan="1">10(27.78)</td><td rowspan="1" colspan="1">10(29.41)</td><td rowspan="1" colspan="1">0.88</td></tr><tr><td rowspan="1" colspan="1">Diabetes (%)</td><td rowspan="1" colspan="1">5(7.14)</td><td rowspan="1" colspan="1">2(5.56)</td><td rowspan="1" colspan="1">3(8.82)</td><td rowspan="1" colspan="1">0.596</td></tr><tr><td rowspan="1" colspan="1">Arrhythmia (%)</td><td rowspan="1" colspan="1">8(11.43)</td><td rowspan="1" colspan="1">5(13.89)</td><td rowspan="1" colspan="1">3(8.82)</td><td rowspan="1" colspan="1">0506</td></tr><tr><td rowspan="1" colspan="1">Hb (g/L)</td><td rowspan="1" colspan="1">127.88±9.37</td><td rowspan="1" colspan="1">125.46±7.91</td><td rowspan="1" colspan="1">130.38±10.19</td><td rowspan="1" colspan="1">0.028</td></tr><tr><td rowspan="1" colspan="1">ALT (U/L)</td><td rowspan="1" colspan="1">18.43±9.65</td><td rowspan="1" colspan="1">16.08±7.58</td><td rowspan="1" colspan="1">20.91±11.03</td><td rowspan="1" colspan="1">0.036</td></tr><tr><td rowspan="1" colspan="1">AST (U/L)</td><td rowspan="1" colspan="1">19.87±8.29</td><td rowspan="1" colspan="1">17.39±3.44</td><td rowspan="1" colspan="1">22.5±10.83</td><td rowspan="1" colspan="1">0.009</td></tr><tr><td rowspan="1" colspan="1">ADA (U/L)</td><td rowspan="1" colspan="1">7.98±2.06</td><td rowspan="1" colspan="1">7.32±1.64</td><td rowspan="1" colspan="1">8.68±2.24</td><td rowspan="1" colspan="1">0.005</td></tr><tr><td rowspan="1" colspan="1">TBIL (μmol/L)</td><td rowspan="1" colspan="1">11.56±3.62</td><td rowspan="1" colspan="1">10.03±2.81</td><td rowspan="1" colspan="1">13.14±3.71</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">DBIL (μmol/L)</td><td rowspan="1" colspan="1">2.26±0.69</td><td rowspan="1" colspan="1">1.99±0.46</td><td rowspan="1" colspan="1">2.52±0.77</td><td rowspan="1" colspan="1">0.002</td></tr><tr><td rowspan="1" colspan="1">PS (%)</td><td rowspan="1" colspan="1">78.49±17.1</td><td rowspan="1" colspan="1">84.34±16.75</td><td rowspan="1" colspan="1">72.47±15.49</td><td rowspan="1" colspan="1">0.003</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: OSA, obstructive sleep apnea; BMI, body mass index; CCS scale, Canada cardiovascular society grading scale for angina; Hb, hemoglobin; ALT, alanine transaminase; AST, aspartate transaminase; ADA, adenosine deaminase; TBIL, total bilirubin; DBIL, direct bilirubin; PS, plasma protein S.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
        <p><citation_analysis attribute="positive">In a state of rest, there exists no statistically significant variance in SRS between patients afflicted with OSA and those without. However, subsequent to undergoing mental stress testing, a significant difference in SSS and SDS was observed between the two patient groups (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2A</xref></citation_analysis><citation_analysis attribute="neither">). Furthermore, prior to and following mental stress, patients with OSA exhibited a notably greater prevalence of myocardial perfusion defects (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2B</xref></citation_analysis><citation_analysis attribute="neither">).
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p><citation_analysis attribute="neither">Myocardial Perfusion in OSA and Non-OSA patients. </citation_analysis><citation_analysis attribute="positive"><bold>(A)</bold></citation_analysis><citation_analysis attribute="positive"> There was no discernible variation in myocardial perfusion levels between the two cohorts of patients in a state of rest (SRS). Nevertheless, a noteworthy dissimilarity in myocardial perfusion levels was observed subsequent to mental stress (SSS), and the variance in the degree of alteration before and after was statistically significant (SDS). </citation_analysis><citation_analysis attribute="positive"><bold>(B)</bold></citation_analysis><citation_analysis attribute="positive"> The myocardial perfusion summed score in the OSA group showed a significant improvement after mental stress.</citation_analysis></p></caption><graphic xlink:href="NSS-16-823-g0002" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: OSA, obstructive sleep apnea; SRS, summed rest score; SSS, summed stress score; SDS, summed difference score.</attrib></fig></citation_analysis></p>
        <p><citation_analysis attribute="positive">The results indicate a positive correlation between SSS and REI, as well as between HI and hemoglobin (Hb), and HI and Hb were also found to be positively correlated (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=445219.docx" ext-link-type="uri">Supplemental Table 1</ext-link></underline></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">The present findings suggest that there exists an autonomous correlation between OSA and MSIMI among female patients with ANOCA. In terms of sleep monitoring parameters, MSIMI patients exhibit a greater prevalence of respiratory sleep events and REI compared to those without MSIMI, with the most notable difference being observed in hypoventilation events and HI. However, there was no statistically significant difference in the number of apnea events and AI between the two groups. Furthermore, MSIMI patients display a higher occurrence of oxygen desaturation events and ODI. Simultaneously, our findings indicate that female ANOCA patients with OSA exhibit functional impairment of the heart prior to the emergence of significant coronary stenosis, as evidenced by the deficiency of myocardial blood perfusion (SDS ≥ 3) during heightened mental stress. The correlation between OSA and MSIMI is intricate due to various confounding factors, particularly BMI. Several extensive clinical studies have indicated a strong association between OSA and obstructive coronary heart disease. Moreover, our findings reveal that OSA remains a significant independent risk factor for MSIMI in patients with non-obstructive angina pectoris, even after accounting for common cardiovascular risk factors such as BMI.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Individuals may experience mental stress during the day, while OSA manifests during nocturnal hours. With repeated occurrences over extended periods, a variety of pathophysiological mechanisms may link OSA and MSIMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="positive"> Prolonged and recurrent psychological stress may result in heightened sympathetic nervous system activity, diminished parasympathetic cardiac control, activation of the hypothalamic-pituitary-adrenal (HPA) axis, and increased systemic inflammation. The activation of these physiological systems may result in hemodynamic alterations, modifications in coronary vascular reactivity, platelet activation, and endothelial impairment, ultimately culminating in myocardial ischemia, infarction, or arrhythmia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> Obstructive apnea events have the potential to induce systemic hypoxemia. The recurring reduction in oxygen saturation and potential hypercapnia can trigger a chemical reflex, resulting in heightened vascular sympathetic nerve activity and serum catecholamines. The tachycardia and blood pressure surge that occur at the conclusion of an apneic episode can increase myocardial oxygen demand at the nadir of oxygen saturation, potentially leading to myocardial ischemia and arrhythmic sequelae.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Cardiac autonomic dysfunction may account for the heightened susceptibility to MSIMI observed in patients with OSA. OSA disrupts the mechanisms responsible for regulating heart rate variability, such as the coupling between cardiac and respiratory parasympathetic inputs within the central nervous system, the arterial baroreflex, and the feedback from lung distraction receptors.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="negative"> Consequently, heart rate variability is diminished in individuals with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> Furthermore, OSA patients exhibit a persistent elevation in sympathetic nerve activity during their waking hours.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> Tamisier et al observed that healthy individuals exposed to chronic intermittent hypoxia (IH) for a period of two weeks experienced an increase in sympathetic nerve outflow during the daytime.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="negative"> While the exact correlation between autonomic nervous function and MSIMI remains largely unclear, chronic sympathetic overdrive has been identified as a potential risk factor for MSIMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The present study underscores the significance of OSA as a risk factor for preclinical cardiovascular disease, characterized by functional alterations in the heart prior to the manifestation of observable obstructive coronary stenosis. Additionally, our findings highlight the potential for OSA and MSIMI to synergistically exacerbate cardiovascular damage via a shared mechanism, despite their occurrence at distinct temporal intervals during daily life. These results offer novel insights into the early prevention of cardiovascular diseases.</citation_analysis></p>
      <p><citation_analysis attribute="positive">This report presents several potential limitations. Firstly, the cross-sectional design employed in this study precludes the ability to establish a causal relationship between OSA and MSIMI. Secondly, the research sample is restricted to female ANOCA patients. Nonetheless, this limitation is not deemed significant given that the prevalence of OSA is higher among males than females. Thirdly, the sleep monitoring data utilized in this study was obtained from wearable sleep monitoring devices and corresponds to Level III sleep testing. While laboratory PSG is considered the gold standard for diagnosing OSA, it is relatively expensive and technically complex. As a result, PM has been employed as an alternative diagnostic test for OSA. In 2014, a meta-analysis was conducted to synthesize the available evidence regarding the use of portable monitoring devices as a viable substitute for laboratory PSG in comparative studies aimed at assessing the accuracy of sleep tests for adults with suspected OSA at both level III and level I. The findings of this study confirmed that level III portable devices demonstrate good diagnostic efficacy.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusions</title>
      <p><citation_analysis attribute="neither">In brief, our investigation demonstrates an autonomous correlation between OSA and MSIMI in female ANOCA patients. Individuals with MSIMI exhibit a greater prevalence of OSA. The myocardial blood flow perfusion in patients with OSA is reduced during mental stress. Nonetheless, additional research is necessary to investigate the fundamental mechanisms and prognostic implications of this association.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <sec sec-type="data-availability" id="s0006">
      <title>Data Sharing Statement</title>
      <p><citation_analysis attribute="neither">All data will be shared upon reasonable request to the corresponding authors.</citation_analysis></p>
    </sec>
    <sec id="s0007">
      <title>Ethics Approval and Consent to Participate</title>
      <p><citation_analysis attribute="neither">Ethical approval was given by the medical ethics committee of Guangdong General Hospital with the following reference number: No. 2019-298H-5. All participants gave written informed consent.</citation_analysis></p>
    </sec>
    <sec id="s0008">
      <title>Clinical Trial Registration</title>
      <p><citation_analysis attribute="neither">Trial name: Effect of Mental Stress on Myocardial Perfusion in Women (MS in women); ClinicalTrials.gov Identifier: NCT03982901, </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT03982901" ext-link-type="uri">https://clinicaltrials.gov/ct2/show/NCT03982901</ext-link></underline></citation_analysis><citation_analysis attribute="neither">.</citation_analysis></p>
    </sec>
    <sec id="s0009">
      <title>Author Contributions</title>
      <p><citation_analysis attribute="positive">All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis, and interpretation, or all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</citation_analysis></p>
    </sec>
    <sec sec-type="COI-statement" id="s0010">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors report no conflicts of interest in this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ma</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fei</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Assessing mental stress on myocardial perfusion and myocardial blood flow in women without obstructive coronary disease: protocol for a mechanistic clinical trial</article-title>. <source><italic toggle="yes">BMJ open</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2020-038362</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Johnson</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Shaw</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Buchthal</surname>
<given-names>SD</given-names></string-name>, et al. <article-title>Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2004</year>;<volume>109</volume>(<issue>24</issue>):<fpage>2993</fpage>–<lpage>2999</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.CIR.0000130642.79868.B2</pub-id><pub-id pub-id-type="pmid">15197152</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chaudhry</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Behbahani</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Abnormal heart-rate response during cardiopulmonary exercise testing identifies cardiac dysfunction in symptomatic patients with non-obstructive coronary artery disease</article-title>. <source><italic toggle="yes">Int J Cardiol</italic></source>. <year>2017</year>;<volume>228</volume>:<fpage>114</fpage>–<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijcard.2016.11.235</pub-id><pub-id pub-id-type="pmid">27863351</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wokhlu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pepine</surname>
<given-names>CJ</given-names></string-name>. <article-title>Mental Stress and Myocardial Ischemia: young Women at Risk</article-title>. <source><italic toggle="yes">J Am Heart Assoc</italic></source>. <year>2016</year>;<volume>5</volume>(<issue>9</issue>):<fpage>e004196</fpage>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.116.004196</pub-id><pub-id pub-id-type="pmid">27559073</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Arri</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Redwood</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Marber</surname>
<given-names>MS</given-names></string-name>. <article-title>Mental stress-induced myocardial ischaemia</article-title>. <source><italic toggle="yes">Heart</italic></source>. <year>2016</year>;<volume>102</volume>(<issue>6</issue>):<fpage>472</fpage>–<lpage>480</lpage>. doi:<pub-id pub-id-type="doi">10.1136/heartjnl-2014-307306</pub-id><pub-id pub-id-type="pmid">26729692</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vancheri</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Longo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Vancheri</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Henein</surname>
<given-names>MY</given-names></string-name>. <article-title>Mental Stress and Cardiovascular Health—Part I</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2022</year>;<volume>11</volume>(<issue>12</issue>):<fpage>3353</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm11123353</pub-id><pub-id pub-id-type="pmid">35743423</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Henein</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Vancheri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Longo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Vancheri</surname>
<given-names>F</given-names></string-name>. <article-title>The Impact of Mental Stress on Cardiovascular Health—Part II</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2022</year>;<volume>11</volume>(<issue>15</issue>):<fpage>4405</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm11154405</pub-id><pub-id pub-id-type="pmid">35956022</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Steptoe</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kivimäki</surname>
<given-names>M</given-names></string-name>. <article-title>Stress and cardiovascular disease</article-title>. <source><italic toggle="yes">Nat Rev Cardiol</italic></source>. <year>2012</year>;<volume>9</volume>(<issue>6</issue>):<fpage>360</fpage>–<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrcardio.2012.45</pub-id><pub-id pub-id-type="pmid">22473079</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Strike</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Steptoe</surname>
<given-names>A</given-names></string-name>. <article-title>Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique</article-title>. <source><italic toggle="yes">Psychosom Med</italic></source>. <year>2005</year>;<volume>67</volume>(<issue>2</issue>):<fpage>179</fpage>–<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.psy.0000155663.93160.d2</pub-id><pub-id pub-id-type="pmid">15784781</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lampert</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jain</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Burg</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Batsford</surname>
<given-names>WP</given-names></string-name>, <string-name><surname>McPherson</surname>
<given-names>CA</given-names></string-name>. <article-title>Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2000</year>;<volume>101</volume>(<issue>2</issue>):<fpage>158</fpage>–<lpage>164</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.cir.101.2.158</pub-id><pub-id pub-id-type="pmid">10637203</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Boyle</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Samad</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients</article-title>. <source><italic toggle="yes">Eur J Prev Cardiol</italic></source>. <year>2017</year>;<volume>24</volume>(<issue>6</issue>):<fpage>591</fpage>–<lpage>599</lpage>. doi:<pub-id pub-id-type="doi">10.1177/2047487316686435</pub-id><pub-id pub-id-type="pmid">28067532</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Bonsigore</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Bonsignore</surname>
<given-names>MR</given-names></string-name>. <article-title>Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2007</year>;<volume>29</volume>(<issue>1</issue>):<fpage>156</fpage>–<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00027406</pub-id><pub-id pub-id-type="pmid">17197482</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="webpage"><collab>Wei</collab>. <article-title>A narrative review on obstructive sleep apnea in China: a sleeping giant in disease pathology</article-title>. <comment>Available from:</comment>
<ext-link xlink:href="https://www.heartmindjournal.org/article.asp?issn=2468-6476;year=2022;volume=6;issue=4;spage=232;epage=241;aulast=Wei" ext-link-type="uri">https://www.heartmindjournal.org/article.asp?issn=2468-6476;year=2022;volume=6;issue=4;spage=232;epage=241;aulast=Wei</ext-link>. <date-in-citation>Accessed <month>June</month>
<day>11</day>, 2023</date-in-citation>.</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Polecka</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Olszewska</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Danielski</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Olszewska</surname>
<given-names>E</given-names></string-name>. <article-title>Association between Obstructive Sleep Apnea and Heart Failure in Adults-A Systematic Review</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2023</year>;<volume>12</volume>(<issue>19</issue>):<fpage>6139</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm12196139</pub-id><pub-id pub-id-type="pmid">37834783</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yeghiazarians</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Jneid</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tietjens</surname>
<given-names>JR</given-names></string-name>, et al. <article-title>Obstructive Sleep Apnea and Cardiovascular Disease: a Scientific Statement From the American Heart Association</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2021</year>;<volume>144</volume>(<issue>3</issue>):<fpage>e56</fpage>–<lpage>e67</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIR.0000000000000988</pub-id><pub-id pub-id-type="pmid">34148375</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bhatt</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Motwani</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Insomnia and Cardiovascular Health: exploring the Link Between Sleep Disorders and Cardiac Arrhythmias</article-title>. <source><italic toggle="yes">Curr Cardiol Rep</italic></source>. <year>2023</year>;<volume>25</volume>(<issue>10</issue>):<fpage>1211</fpage>–<lpage>1221</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11886-023-01939-x</pub-id><pub-id pub-id-type="pmid">37656386</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jordan</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>McSharry</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>. <article-title>Adult obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2014</year>;<volume>383</volume>(<issue>9918</issue>):<fpage>736</fpage>–<lpage>747</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60734-5</pub-id><pub-id pub-id-type="pmid">23910433</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="webpage"><collab>Sum-Ping</collab>. <article-title>Impact of Sleep on Cardiovascular Health: a Narrative Review</article-title>. <comment>Available from:</comment>
<ext-link xlink:href="https://www.heartmindjournal.org/article.asp?issn=2468-6476;year=2022;volume=6;issue=3;spage=120;epage=126;aulast=Sum-Ping" ext-link-type="uri">https://www.heartmindjournal.org/article.asp?issn=2468-6476;year=2022;volume=6;issue=3;spage=120;epage=126;aulast=Sum-Ping</ext-link>. <date-in-citation>Accessed <month>June</month>
<day>11</day>, 2023</date-in-citation>.</mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Foster</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Brugniaux</surname>
<given-names>JV</given-names></string-name>, <string-name><surname>Pialoux</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans</article-title>. <source><italic toggle="yes">J Physiol</italic></source>. <year>2009</year>;<volume>587</volume>(<issue>Pt 13</issue>):<fpage>3287</fpage>–<lpage>3299</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2009.171553</pub-id><pub-id pub-id-type="pmid">19417094</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gilmartin</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Lynch</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tamisier</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>JW</given-names></string-name>. <article-title>Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity</article-title>. <source><italic toggle="yes">Am J Physiol Heart Circ Physiol</italic></source>. <year>2010</year>;<volume>299</volume>(<issue>3</issue>):<fpage>H925</fpage>–<lpage>931</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpheart.00253.2009</pub-id><pub-id pub-id-type="pmid">20581089</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ryan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>. <article-title>Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2005</year>;<volume>112</volume>(<issue>17</issue>):<fpage>2660</fpage>–<lpage>2667</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.556746</pub-id><pub-id pub-id-type="pmid">16246965</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lavie</surname>
<given-names>L</given-names></string-name>. <article-title>Obstructive sleep apnoea syndrome--an oxidative stress disorder</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2003</year>;<volume>7</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1053/smrv.2002.0261</pub-id><pub-id pub-id-type="pmid">12586529</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Carlson</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Rångemark</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hedner</surname>
<given-names>JA</given-names></string-name>. <article-title>Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea</article-title>. <source><italic toggle="yes">J Hypertens</italic></source>. <year>1996</year>;<volume>14</volume>(<issue>5</issue>):<fpage>577</fpage>–<lpage>584</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00004872-199605000-00006</pub-id><pub-id pub-id-type="pmid">8762200</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Carlson</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Hedner</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Elam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ejnell</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sellgren</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wallin</surname>
<given-names>BG</given-names></string-name>. <article-title>Augmented Resting Sympathetic Activity in Awake Patients With Obstructive Sleep Apnea</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>1993</year>;<volume>103</volume>(<issue>6</issue>):<fpage>1763</fpage>–<lpage>1768</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.103.6.1763</pub-id><pub-id pub-id-type="pmid">8404098</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Carneiro</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Azoubel</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Dias</surname>
<given-names>RC</given-names></string-name>, et al. <article-title>Correlation of sleep quality and cardiac autonomic modulation in hemodialysis patients</article-title>. <source><italic toggle="yes">Sleep Sci</italic></source>. <year>2022</year>;<volume>15</volume>(<issue>Spec 1</issue>):<fpage>59</fpage>–<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.5935/1984-0063.20200126</pub-id><pub-id pub-id-type="pmid">35273748</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ooi</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Rajendran</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Munawar</surname>
<given-names>DA</given-names></string-name>, et al. <article-title>The Association of Obstructive Sleep Apnea in Ischemia with No Obstructive Coronary Artery Disease - A Pilot Study</article-title>. <source><italic toggle="yes">Curr Probl Cardiol</italic></source>. <year>2023</year>;<volume>48</volume>(<issue>5</issue>):<fpage>101111</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cpcardiol.2022.101111</pub-id><pub-id pub-id-type="pmid">35021111</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sateia</surname>
<given-names>MJ</given-names></string-name>. <article-title>International classification of sleep disorders-third edition: highlights and modifications</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2014</year>;<volume>146</volume>(<issue>5</issue>):<fpage>1387</fpage>–<lpage>1394</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.14-0970</pub-id><pub-id pub-id-type="pmid">25367475</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kapur</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Auckley</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Chowdhuri</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: an American Academy of Sleep Medicine Clinical Practice Guideline</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2012</year>;<volume>13</volume>(<issue>03</issue>):<fpage>479</fpage>–<lpage>504</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.6506</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Park</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>H</given-names></string-name>. <article-title>Modulation of sleep using noninvasive stimulations during sleep</article-title>. <source><italic toggle="yes">Biomed Eng Lett</italic></source>. <year>2023</year>;<volume>13</volume>(<issue>3</issue>):<fpage>329</fpage>–<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13534-023-00298-4</pub-id><pub-id pub-id-type="pmid">37519871</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Souza de</surname>
<given-names>LFF</given-names></string-name>, <string-name><surname>Paineiras-Domingos</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Melo-Oliveira de</surname>
<given-names>ME</given-names></string-name>, et al. <article-title>The impact of COVID-19 pandemic in the quality of sleep by Pittsburgh Sleep Quality Index: a systematic review</article-title>. <source><italic toggle="yes">Cien Saude Colet</italic></source>. <year>2021</year>;<volume>26</volume>(<issue>4</issue>):<fpage>1457</fpage>–<lpage>1466</lpage>. doi:<pub-id pub-id-type="doi">10.1590/1413-81232021264.45952020</pub-id><pub-id pub-id-type="pmid">33886773</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Oliveira</surname>
<given-names>ACT</given-names></string-name>, <string-name><surname>Martinez</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Vasconcelos</surname>
<given-names>LFT</given-names></string-name>, et al. <article-title>Diagnosis of obstructive sleep apnea syndrome and its outcomes with home portable monitoring</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2009</year>;<volume>135</volume>(<issue>2</issue>):<fpage>330</fpage>–<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.08-1859</pub-id><pub-id pub-id-type="pmid">19201709</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>El Shayeb</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Topfer</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Stafinski</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Pawluk</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Menon</surname>
<given-names>D</given-names></string-name>. <article-title>Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">CMAJ</italic></source>. <year>2014</year>;<volume>186</volume>(<issue>1</issue>):<fpage>E25</fpage>–<lpage>E51</lpage>. doi:<pub-id pub-id-type="doi">10.1503/cmaj.130952</pub-id><pub-id pub-id-type="pmid">24218531</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ma</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fei</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Assessing mental stress on myocardial perfusion and myocardial blood flow in women without obstructive coronary disease: protocol for a mechanistic clinical trial</article-title>. <source><italic toggle="yes">BMJ Open</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e038362</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2020-038362</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pereira</surname>
<given-names>VH</given-names></string-name>, <string-name><surname>Cerqueira</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Palha</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Sousa</surname>
<given-names>N</given-names></string-name>. <article-title>Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology</article-title>. <source><italic toggle="yes">Int J Cardiol</italic></source>. <year>2013</year>;<volume>166</volume>(<issue>1</issue>):<fpage>30</fpage>–<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijcard.2012.03.165</pub-id><pub-id pub-id-type="pmid">22521375</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lévy</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kohler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>, et al. <article-title>Obstructive sleep apnoea syndrome</article-title>. <source><italic toggle="yes">Nat Rev Dis Primers</italic></source>. <year>2015</year>;<volume>1</volume>:<fpage>15015</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nrdp.2015.15</pub-id><pub-id pub-id-type="pmid">27188535</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hall</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Ziadi</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Leech</surname>
<given-names>JA</given-names></string-name>, et al. <article-title>Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2014</year>;<volume>130</volume>(<issue>11</issue>):<fpage>892</fpage>–<lpage>901</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.005893</pub-id><pub-id pub-id-type="pmid">24993098</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Roche</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Xuong</surname>
<given-names>ANT</given-names></string-name>, <string-name><surname>Court-Fortune</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance</article-title>. <source><italic toggle="yes">Pacing Clin Electrophysiol</italic></source>. <year>2003</year>;<volume>26</volume>(<issue>3</issue>):<fpage>669</fpage>–<lpage>677</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1460-9592.2003.00116.x</pub-id><pub-id pub-id-type="pmid">12698666</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Dyken</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Clary</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Abboud</surname>
<given-names>FM</given-names></string-name>. <article-title>Sympathetic neural mechanisms in obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Clin Invest</italic></source>. <year>1995</year>;<volume>96</volume>(<issue>4</issue>):<fpage>1897</fpage>–<lpage>1904</lpage>.<pub-id pub-id-type="pmid">7560081</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tamisier</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Pépin</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Rémy</surname>
<given-names>J</given-names></string-name>, et al. <article-title>14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2011</year>;<volume>37</volume>(<issue>1</issue>):<fpage>119</fpage>–<lpage>128</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00204209</pub-id><pub-id pub-id-type="pmid">20525723</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
